Physician profile
Michael Mcclure
NPI 1821106535
$4,001.67
in general payments reported to CMS, 2019-2025
11 companies · $449 in 2025
The $449 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,022 · 2020: $308 · 2021: $479 · 2022: $852 · 2023: $561 · 2024: $331 · 2025: $449.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,339.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,583.05 | 2019-2025 | Mako, Axsos |
| Zimmer Biomet Holdings, INC. | $667.82 | 2019-2025 | Persona, Comprehensive Shoulder System, Synovasure Alpha Defensin |
| Medacta USA, INC. | $161.49 | 2020 | |
| Smith+Nephew, INC. | $129.55 | 2019 | |
| Baxter Healthcare | $112.01 | 2022 | |
| Medical Device Business Services, INC. | $108.67 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $98.16 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $57.02 | 2024-2025 | |
| Depuy Synthes Sales INC. | $47.47 | 2022 | |
| Abbott Laboratories | $20.92 | 2025 | Proclaim |
| Fidia Pharma USA INC. | $15.51 | 2025 | Triluron, Hymovis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcclure listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.